Chem. J. Chinese Universities ›› 2023, Vol. 44 ›› Issue (3): 20220363.doi: 10.7503/cjcu20220363

• Review • Previous Articles     Next Articles

Applications of Gene Editing in Mitochondrial Diseases

CHANG Liying1,2,3, LING Xinyu1,2,3, CHEN Heqi1,2,3, WANG Xue1,2,3, LIU Tao1,2,3()   

  1. 1.State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Beijing 100191,China
    2.Chemical Biology Center,Peking University,Beijing 100191,China
    3.Department of Molecular and Cellular Pharmacology,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China
  • Received:2022-05-21 Online:2023-03-10 Published:2023-03-14
  • Contact: LIU Tao E-mail:taoliupku@pku.edu.cn
  • Supported by:
    the National Key Research and Development Program for Synthetic Biology, China(2021YFA0909900);the Outstanding Youth Fund of the National Science Foundation of China(21922701);the Outstanding Youth Program of Beijing, China(JQ20034)

Abstract:

Mitochondria, as energy factories of cells, play an important role in maintaining cell energy metabolism and human life activities. The mutations of mitochondrial genome have led to a series of mitochondrial diseases, which seriously threaten human life and health. The development of gene editing methods targeting mitochondria is of great significance for the treatment of mitochondrial diseases. In recent years, a series of gene editing methods inclu-ding restriction nuclease, zinc finger nuclease, transcriptional activator like effector nuclease, clustered regularly interspaced short palindromic repeats(CRISPR) and mitochondrial base editor have been developed. This article reviewed the recent progresses, deficiencies and prospects of the applications of gene editing tools for mitochondria gene editing. We hope it could provide reference for the development of mitochondrial disease treatment.

Key words: Mitochondrial diseases, Mitochondrial heteroplasmy, Gene editing

CLC Number: 

TrendMD: